These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12537998)

  • 1. Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. synthesis and biological evaluation of dihydropyridin-2(1H)-imines and 1,5,6,7-tetrahydro-2H-azepin-2-imines.
    Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Nishizaki M; Naka M; Komeno M; Nakai H; Toda M
    Bioorg Med Chem; 2003 Mar; 11(5):689-702. PubMed ID: 12537998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Part 1: synthesis and biological evaluation of dihydropyridin-2-imines.
    Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Naka M; Komeno M; Nakai H; Toda M
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2291-4. PubMed ID: 12161118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Identification of 2-azabicyclo[4.1.0]heptan-3-imines.
    Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Naka M; Komeno M; Odagaki Y; Nakai H; Toda M
    Bioorg Med Chem; 2003 Apr; 11(8):1723-43. PubMed ID: 12659759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS).
    Hansen DW; Peterson KB; Trivedi M; Kramer SW; Webber RK; Tjoeng FS; Moore WM; Jerome GM; Kornmeier CM; Manning PT; Connor JR; Misko TP; Currie MG; Pitzele BS
    J Med Chem; 1998 Apr; 41(9):1361-6. PubMed ID: 9554868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of inhibitors of inducible nitric oxide synthase. Discovery of a new chemical lead with potential for oral bioavailability.
    Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Naka M; Komeno M; Nakai H; Toda M
    Eur J Med Chem; 2003 Mar; 38(3):277-88. PubMed ID: 12667694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase.
    Hagen TJ; Bergmanis AA; Kramer SW; Fok KF; Schmelzer AE; Pitzele BS; Swenton L; Jerome GM; Kornmeier CM; Moore WM; Branson LF; Connor JR; Manning PT; Currie MG; Hallinan EA
    J Med Chem; 1998 Sep; 41(19):3675-83. PubMed ID: 9733492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms.
    Webber RK; Metz S; Moore WM; Connor JR; Currie MG; Fok KF; Hagen TJ; Hansen DW; Jerome GM; Manning PT; Pitzele BS; Toth MV; Trivedi M; Zupec ME; Tjoeng FS
    J Med Chem; 1998 Jan; 41(1):96-101. PubMed ID: 9438025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel and orally bioavailable inducible nitric oxide synthase inhibitors: synthesis and evaluation of optically active 4,5-dialkyl-2-iminoselenazolidine derivatives.
    Ueda S; Terauchi H; Suzuki K; Yano A; Matsumoto M; Kubo T; Minato H; Arai Y; Tsuji J; Watanabe N
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1361-6. PubMed ID: 15713387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Hydroxy-4-methyl-5-pentyl-2-iminopyrrolidine: a potent and highly selective inducible nitric oxide synthase inhibitor.
    Tsymbalov S; Hagen TJ; Moore WM; Jerome GM; Connor JR; Manning PT; Pitzele BS; Hallinan EA
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3337-9. PubMed ID: 12392746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetamidine lysine derivative, N-(5(S)-amino-6,7-dihydroxyheptyl)ethanimidamide dihydrochloride: a highly selective inhibitor of human inducible nitric oxide synthase.
    Hallinan EA; Tsymbalov S; Finnegan PM; Moore WM; Jerome GM; Currie MG; Pitzele BS
    J Med Chem; 1998 Mar; 41(6):775-7. PubMed ID: 9526553
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and evaluation of trans 3,4-cyclopropyl L-arginine analogues as isoform selective inhibitors of nitric oxide synthase.
    Fishlock D; Perdicakis B; Montgomery HJ; Guillemette JG; Jervis E; Lajoie GA
    Bioorg Med Chem; 2003 Mar; 11(6):869-73. PubMed ID: 12614872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1H-pyrazole-1-carboxamidines: new inhibitors of nitric oxide synthase.
    Lee Y; Martásek P; Roman LJ; Silverman RB
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2771-4. PubMed ID: 11133088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pyrrolidin-2-imines and 1,3-thiazolidin-2-imines as inhibitors of nitric oxide synthase.
    Shankaran K; Donnelly KL; Shah SK; Guthikonda RN; MacCoss M; Humes JL; Pacholok SG; Grant SK; Kelly TM; Wong KK
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4539-44. PubMed ID: 15357988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and characterization of a novel class of coumarin-based inhibitors of inducible nitric oxide synthase.
    Jackson SA; Sahni S; Lee L; Luo Y; Nieduzak TR; Liang G; Chiang Y; Collar N; Fink D; He W; Laoui A; Merrill J; Boffey R; Crackett P; Rees B; Wong M; Guilloteau JP; Mathieu M; Rebello SS
    Bioorg Med Chem; 2005 Apr; 13(8):2723-39. PubMed ID: 15781384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and evaluation of new type of L-amino acids containing pyridine moiety as nitric oxide synthase inhibitor.
    Ijuin R; Umezawa N; Higuchi T
    Bioorg Med Chem; 2006 May; 14(10):3563-70. PubMed ID: 16466923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
    Hah JM; Martásek P; Roman LJ; Silverman RB
    J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thienopyridines: nitric oxide synthase inhibitors with potent in vivo activity.
    Beaton H; Boughton-Smith N; Hamley P; Ghelani A; Nicholls DJ; Tinker AC; Wallace AV
    Bioorg Med Chem Lett; 2001 Apr; 11(8):1027-30. PubMed ID: 11327581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bicyclic amidine inhibitors of nitric oxide synthase: discovery of perhydro-iminopyrindine and perhydro-iminoquinoline as potent, orally active inhibitors of inducible nitric oxide synthase.
    Guthikonda RN; Shah SK; Pacholok SG; Humes JL; Mumford RA; Grant SK; Chabin RM; Green BG; Tsou N; Ball R; Fletcher DS; Luell S; Euan MacIntyre D; Maccoss M
    Bioorg Med Chem Lett; 2005 Apr; 15(8):1997-2001. PubMed ID: 15808455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.
    Tinker AC; Beaton HG; Boughton-Smith N; Cook TR; Cooper SL; Fraser-Rae L; Hallam K; Hamley P; McInally T; Nicholls DJ; Pimm AD; Wallace AV
    J Med Chem; 2003 Mar; 46(6):913-6. PubMed ID: 12620067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4,5-dialkylsubstituted 2-imino-1,3-thiazolidine derivatives as potent inducible nitric oxide synthase inhibitors.
    Ueda S; Terauchi H; Yano A; Matsumoto M; Kubo T; Kyoya Y; Suzuki K; Ido M; Kawasaki M
    Bioorg Med Chem; 2004 Aug; 12(15):4101-16. PubMed ID: 15246088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.